Looking forward to our plans for 2021: SGD Pharma starts major Sucy-en-Brie plant development project

I was proud and happy to visit the Sucy-en-Brie plant this week and to meet the very dedicated team in charge of a major revamping of the factory, coordinated by Philippe Dubois (photo). The project, which will last till March 2021, has now broken ground. This Capex, 31 million€ in total, is the biggest SGD Pharma investment since the Saint-Quentin-Lamotte plant construction.

How Does SGD Pharma Envision the Future of the Pharma/Biopharma Industry?

Source: Pharma's Almanac - December 2020 

SGD Pharma, one of That's Nice's Road to 2021 sponsors, discusses how the company is envisioning the future of the pharma/biopharma industry.

Moulded glass vials secure COVID-19 vaccine supply

4-Dec-2020 - Manufacturing Chemist - https://manufacturingchemist.com/news/article_page/Moulded_glass_vials_s...

Although different materials have been trialled and tested, glass remains the most widely used type of primary container for parenteral drug products, writes Dr Jingwei Zhang, R&D Director, SGD Pharma

Securing the global injectable vial supply with molded glass

Source: Pharmacy & Packaging - December 2020 

Laurent Millet : "Assessed by EcoVadis, SGD Pharma is in the top 10% of its activity sector."

Interview / Laurent Millet - The Pharmaceutical Post Q4 - December 2020

[Breaking news]

We are proud to announce that Saint-Quentin-Lamotte plant, Center of Excellence for Type I glass, has strived to Zero accident this year.

Thank you to everyone at the site for this challenge brilliantly met!

Discover all key features and benefits of plastic coating options offered by SGD Pharma 

Business as usual despite lockdown restrictions